| Stage | ENS | % of rev | AMKR | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $936M | 100.00% | $2.0B | 100.00% | AMKR ×2.13 |
| Gross profit | $313M | 33.49% | $364M | 18.26% | ENS +15.2pp |
| Operating income | $151M | 16.18% | $225M | 11.29% | ENS +4.9pp |
| Pre-tax income | $135M | 14.43% | $230M | 11.56% | ENS +2.9pp |
| Net income | $116M | 12.45% | $191M | 9.59% | ENS +2.9pp |
| Stage | ENS | AMKR | Gap · A − B |
|---|---|---|---|
| Revenue | $936M100.00% | $2.0B100.00% | AMKR ×2.13 |
| Gross profit | 33.49%$313M | 18.26%$364M | ENS +15.2pp |
| Operating income | 16.18%$151M | 11.29%$225M | ENS +4.9pp |
| Pre-tax income | 14.43%$135M | 11.56%$230M | ENS +2.9pp |
| Net income | 12.45%$116M | 9.59%$191M | ENS +2.9pp |
No shared counterparties.